Hepatitis C SIG: Improving the Care Continuum for Chronic HCV Infection in 2019

2 (1 vote)

Recorded On: 11/08/2019

Review steps to develop programs to eradicate HCV in the U.S. at this program. Speakers will address the current state of screening, novel models to engage more patients into therapy and the current state of access to HCV therapeutics, including generics. They will contrast U.S. efforts to eradicate HCV with programs from around the world.

Sanjeev Arora
Jonathan Fenkel
Camilla Graham
Lynn Taylor
David Thomas

Key:

Complete
Failed
Available
Locked
Current State of the HCV Care Cascade
Open to view video.
Open to view video. Presenter: David L. Thomas
Novel Tests and Strategies in HCV Screening
Open to view video.
Open to view video. Presenter: Jonathan M. Fenkel
Novel Models of HCV Care Delivery
Open to view video.
Open to view video. Presenter: Sanjeev Arora
Co-Localization in HCV Care
Open to view video.
Open to view video. Presenter: Lynn E. Taylor
Current Status of U.S. and Global Drug Access
Open to view video.
Open to view video. Presenter: Camilla S. Graham
Final Evaluation
Final Evaluation
7 Questions
7 Questions Please complete the following evaluation form to share your feedback on this activity.